Baseline characteristics of all patients in the study
| Characteristic . | Received ESA . | Did not receive ESA . | ||||||
|---|---|---|---|---|---|---|---|---|
| No. . | % . | Mean . | SD . | No. . | % . | Mean . | SD . | |
| Total No. of patients | 113 | 457 | ||||||
| CKD | 13 | 12 | 12 | 3 | ||||
| MDS | 52 | 46 | 147 | 32 | ||||
| AUE | 21 | 19 | 96 | 21 | ||||
| Other etiology | 27 | 24 | 202 | 44 | ||||
| Male sex | 68 | 60 | 274 | 60 | ||||
| Age, y | 75.1 | 8.7 | 75.9 | 8.1 | ||||
| Weight, kg | 78.5 | 19.7 | 74.6 | 18.0 | ||||
| Comorbidity index | 2.2 | 1.7 | 1.4 | 1.4 | ||||
| Hemoglobin, g/L | 88.5 | 12.8 | 97.7 | 15.9 | ||||
| EPO, IU/L | 135.2 | 420.0 | 187.2 | 539.3 | ||||
| eGFR, mL/min/1.73 m2 | 46.6 | 24.3 | 61.0 | 22.4 | ||||
| Other cytopenia | 45 | 40 | 175 | 38 | ||||
| Characteristic . | Received ESA . | Did not receive ESA . | ||||||
|---|---|---|---|---|---|---|---|---|
| No. . | % . | Mean . | SD . | No. . | % . | Mean . | SD . | |
| Total No. of patients | 113 | 457 | ||||||
| CKD | 13 | 12 | 12 | 3 | ||||
| MDS | 52 | 46 | 147 | 32 | ||||
| AUE | 21 | 19 | 96 | 21 | ||||
| Other etiology | 27 | 24 | 202 | 44 | ||||
| Male sex | 68 | 60 | 274 | 60 | ||||
| Age, y | 75.1 | 8.7 | 75.9 | 8.1 | ||||
| Weight, kg | 78.5 | 19.7 | 74.6 | 18.0 | ||||
| Comorbidity index | 2.2 | 1.7 | 1.4 | 1.4 | ||||
| Hemoglobin, g/L | 88.5 | 12.8 | 97.7 | 15.9 | ||||
| EPO, IU/L | 135.2 | 420.0 | 187.2 | 539.3 | ||||
| eGFR, mL/min/1.73 m2 | 46.6 | 24.3 | 61.0 | 22.4 | ||||
| Other cytopenia | 45 | 40 | 175 | 38 | ||||